CDC- BRFSS – ACBS 2020 Adult Prevalence Table 2b
State/Territory | Sample size± |
Attack in past 3 months | No attack or symptoms in past 3 months | ||||||
---|---|---|---|---|---|---|---|---|---|
Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE§ | 95% CI† | ||
Arizona | 304 | 137 | 44.9 | 4.5 | (36.1 – 53.7) | 167 | 55.1 | 4.5 | (46.3 – 63.9) |
Connecticut | 298 | 92 | 28.2 | 4.1 | (20.2 – 36.2) | 206 | 71.8 | 4.1 | (63.8 – 79.8) |
Florida | 279 | 116 | 42.9 | 5.6 | (31.9 – 53.9) | 163 | 57.1 | 5.6 | (46.1 – 68.1) |
Georgia | 266 | 114 | 38.2 | 5.3 | (27.8 – 48.6) | 152 | 61.8 | 5.3 | (51.4 – 72.2) |
Hawaii | 231 | 70 | 23.7 | 3.5 | (16.8 – 30.6) | 161 | 76.3 | 3.5 | (69.4 – 83.2) |
Indiana | 282 | 125 | 45.5 | 4.0 | (37.7 – 53.3) | 157 | 54.5 | 4.0 | (46.7 – 62.3) |
Iowa | 276 | 87 | 34.4 | 3.5 | (27.5 – 41.3) | 189 | 65.6 | 3.5 | (58.7 – 72.5) |
Kansas | 180 | 42 | 20.4 | 4.3 | (12.0 – 28.8) | 138 | 79.6 | 4.3 | (71.2 – 88.0) |
Maine | 380 | 123 | 32.8 | 4.5 | (24.0 – 41.6) | 257 | 67.2 | 4.5 | (58.4 – 76.0) |
Maryland | 147 | 54 | 30.3 | 4.9 | (20.7 – 39.9) | 93 | 69.7 | 4.9 | (60.1 – 79.3) |
Massachusetts | 231 | 65 | 31.2 | 4.4 | (22.6 – 39.8) | 166 | 68.8 | 4.4 | (60.2 – 77.4) |
Michigan | 324 | 116 | 35.5 | 3.7 | (28.2 – 42.8) | 208 | 64.5 | 3.7 | (57.2 – 71.8) |
Minnesota | 470 | 163 | 34.8 | 2.8 | (29.3 – 40.3) | 307 | 65.2 | 2.8 | (59.7 – 70.7) |
Missouri | 248 | 89 | 38.4 | 4.9 | (28.8 – 48.0) | 159 | 61.6 | 4.9 | (52.0 – 71.2) |
Montana | 233 | 74 | 32.5 | 4.2 | (24.3 – 40.7) | 159 | 67.5 | 4.2 | (59.3 – 75.7) |
Nebraska | 413 | 139 | 33.1 | 3.6 | (26.0 – 40.2) | 274 | 66.9 | 3.6 | (59.8 – 74.0) |
New Hampshire | 367 | 134 | 37.0 | 3.6 | (29.9 – 44.1) | 233 | 63.0 | 3.6 | (55.9 – 70.1) |
New Jersey | 440 | 148 | 33.1 | 2.9 | (27.4 – 38.8) | 292 | 66.9 | 2.9 | (61.2 – 72.6) |
New Mexico | 243 | 95 | 34.9 | 4.9 | (25.3 – 44.5) | 148 | 65.1 | 4.9 | (55.5 – 74.7) |
New York | 178 | 54 | 29.7 | 5.1 | (19.7 – 39.7) | 124 | 70.3 | 5.1 | (60.3 – 80.3) |
Ohio | 406 | 145 | 34.9 | 3.6 | (27.8 – 42.0) | 261 | 65.1 | 3.6 | (58.0 – 72.2) |
Oregon | 225 | 82 | 33.9 | 3.8 | (26.5 – 41.3) | 143 | 66.1 | 3.8 | (58.7 – 73.5) |
Pennsylvania | 176 | 65 | 41.2 | 5.5 | (30.4 – 52.0) | 111 | 58.8 | 5.5 | (48.0 – 69.6) |
Rhode Island | 229 | 71 | 33.4 | 5.3 | (23.0 – 43.8) | 158 | 66.6 | 5.3 | (56.2 – 77.0) |
Texas | 382 | 164 | 38.2 | 4.8 | (28.8 – 47.6) | 218 | 61.8 | 4.8 | (52.4 – 71.2) |
Utah | 352 | 136 | 41.7 | 3.5 | (34.8 – 48.6) | 216 | 58.3 | 3.5 | (51.4 – 65.2) |
Vermont | 372 | 111 | 31.6 | 3.8 | (24.2 – 39.0) | 261 | 68.4 | 3.8 | (61.0 – 75.8) |
Wisconsin | 224 | 83 | 37.9 | 4.6 | (28.9 – 46.9) | 141 | 62.1 | 4.6 | (53.1 – 71.1) |
Puerto Rico | 219 | 46 | 27.0 | 5.6 | (16.0 – 38.0) | 173 | 73.0 | 5.6 | (62.0 – 84.0) |
29 States / Area | 8,375 | 2,940 | 35.9 | 1.1 | (33.7 – 38.1) | 5,435 | 64.1 | 1.1 | (61.9 – 66.3) |
Median | 34.4 | 65.6 | |||||||
Range | 20.4-45.5 | 54.5-79.6 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf